Osaic Holdings’s Cognition Therapeutics CGTX Stock Holding History

Osaic Holdings’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.83K	Buy	4,200 +1,000	+31%	+$1.18K	﹤0.01%	6950
2026 Q1	$2.43K	Sell	3,200 -1,400	-30%	-$1.63K	﹤0.01%	6983
2025 Q4	$6.21K	Sell	4,600 -8,000	-63%	-$13K	﹤0.01%	6575
2025 Q3	$18K	Buy	+12,600	New	+$17.2K	﹤0.01%	6000
2025 Q2	–	Sell	-7,200	Closed	-$3.02K	–	7759
2025 Q1	$3.02K	Sell	7,200 -11,800	-62%	-$6.93K	﹤0.01%	6432
2024 Q4	$13.3K	Buy	19,000 +17,200	+956%	+$8.5K	﹤0.01%	5610
2024 Q3	$846	Buy	+1,800	New	+$1.86K	﹤0.01%	6885
2024 Q2	–	Sell	-1,165	Closed	-$2.12K	–	7433
2024 Q1	$2.12K	Buy	+1,165	New	+$2.4K	﹤0.01%	6447

Other funds holding CGTX

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HCM

Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Osaic Holdings's CGTX Position: Q2 2026 in Review

Osaic Holdings increased its Cognition Therapeutics (CGTX) stake by 31% in Q2 2026, buying an estimated $1.18K and bringing the position to 4,200 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #6950.

Osaic Holdings first reported a position in CGTX in Q1 2024 and has held it in 8 quarters since. The position peaked at $18K in Q3 2025. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

Osaic Holdings held 4,200 shares of Cognition Therapeutics worth $4.83K as of Q2 2026.
Osaic Holdings bought 1,000 Cognition Therapeutics shares in Q2 2026, an estimated $1.18K.
Cognition Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6950 holding.
Osaic Holdings first reported a position in Cognition Therapeutics in Q1 2024 and has held it in 8 quarters since.
Osaic Holdings's Cognition Therapeutics position peaked at $18K in Q3 2025.
66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.